PortfoliosLab logo
AES vs. ABT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between AES and ABT is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


Performance

AES vs. ABT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The AES Corporation (AES) and Abbott Laboratories (ABT). The values are adjusted to include any dividend payments, if applicable.

0.00%1,000.00%2,000.00%3,000.00%4,000.00%5,000.00%December2025FebruaryMarchAprilMay
447.82%
5,173.31%
AES
ABT

Key characteristics

Sharpe Ratio

AES:

-0.96

ABT:

1.48

Sortino Ratio

AES:

-1.26

ABT:

2.09

Omega Ratio

AES:

0.84

ABT:

1.27

Calmar Ratio

AES:

-0.50

ABT:

1.15

Martin Ratio

AES:

-1.18

ABT:

7.00

Ulcer Index

AES:

33.38%

ABT:

4.20%

Daily Std Dev

AES:

43.03%

ABT:

20.59%

Max Drawdown

AES:

-98.65%

ABT:

-45.66%

Current Drawdown

AES:

-76.89%

ABT:

-3.99%

Fundamentals

Market Cap

AES:

$7.25B

ABT:

$230.70B

EPS

AES:

$1.84

ABT:

$7.70

PE Ratio

AES:

5.53

ABT:

17.22

PEG Ratio

AES:

1.09

ABT:

4.17

PS Ratio

AES:

0.60

ABT:

5.33

PB Ratio

AES:

2.09

ABT:

4.69

Total Revenue (TTM)

AES:

$12.12B

ABT:

$42.34B

Gross Profit (TTM)

AES:

$2.14B

ABT:

$23.67B

EBITDA (TTM)

AES:

$3.01B

ABT:

$11.20B

Returns By Period

In the year-to-date period, AES achieves a -13.06% return, which is significantly lower than ABT's 19.64% return. Over the past 10 years, AES has underperformed ABT with an annualized return of 1.31%, while ABT has yielded a comparatively higher 13.13% annualized return.


AES

YTD

-13.06%

1M

7.66%

6M

-18.03%

1Y

-41.05%

5Y*

0.02%

10Y*

1.31%

ABT

YTD

19.64%

1M

8.61%

6M

17.37%

1Y

30.26%

5Y*

9.37%

10Y*

13.13%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

AES vs. ABT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

AES
The Risk-Adjusted Performance Rank of AES is 1313
Overall Rank
The Sharpe Ratio Rank of AES is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of AES is 99
Sortino Ratio Rank
The Omega Ratio Rank of AES is 1111
Omega Ratio Rank
The Calmar Ratio Rank of AES is 2121
Calmar Ratio Rank
The Martin Ratio Rank of AES is 2121
Martin Ratio Rank

ABT
The Risk-Adjusted Performance Rank of ABT is 8888
Overall Rank
The Sharpe Ratio Rank of ABT is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of ABT is 8787
Sortino Ratio Rank
The Omega Ratio Rank of ABT is 8585
Omega Ratio Rank
The Calmar Ratio Rank of ABT is 8686
Calmar Ratio Rank
The Martin Ratio Rank of ABT is 9191
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

AES vs. ABT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The AES Corporation (AES) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The current AES Sharpe Ratio is -0.96, which is lower than the ABT Sharpe Ratio of 1.48. The chart below compares the historical Sharpe Ratios of AES and ABT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.50December2025FebruaryMarchAprilMay
-0.96
1.48
AES
ABT

Dividends

AES vs. ABT - Dividend Comparison

AES's dividend yield for the trailing twelve months is around 6.45%, more than ABT's 1.70% yield.


TTM20242023202220212020201920182017201620152014
AES
The AES Corporation
6.45%5.38%3.45%2.20%2.49%2.43%2.75%3.60%4.43%3.79%4.18%1.45%
ABT
Abbott Laboratories
1.70%1.95%1.85%1.71%1.28%1.32%1.47%1.55%1.86%2.71%2.14%1.95%

Drawdowns

AES vs. ABT - Drawdown Comparison

The maximum AES drawdown since its inception was -98.65%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for AES and ABT. For additional features, visit the drawdowns tool.


-80.00%-60.00%-40.00%-20.00%0.00%December2025FebruaryMarchAprilMay
-76.89%
-3.99%
AES
ABT

Volatility

AES vs. ABT - Volatility Comparison

The AES Corporation (AES) has a higher volatility of 15.46% compared to Abbott Laboratories (ABT) at 5.53%. This indicates that AES's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2025FebruaryMarchAprilMay
15.46%
5.53%
AES
ABT

Financials

AES vs. ABT - Financials Comparison

This section allows you to compare key financial metrics between The AES Corporation and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


2.00B4.00B6.00B8.00B10.00B12.00B20212022202320242025
2.93B
10.36B
(AES) Total Revenue
(ABT) Total Revenue
Values in USD except per share items

AES vs. ABT - Profitability Comparison

The chart below illustrates the profitability comparison between The AES Corporation and Abbott Laboratories over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

10.0%20.0%30.0%40.0%50.0%60.0%20212022202320242025
15.1%
56.9%
(AES) Gross Margin
(ABT) Gross Margin
AES - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, The AES Corporation reported a gross profit of 441.00M and revenue of 2.93B. Therefore, the gross margin over that period was 15.1%.

ABT - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.

AES - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, The AES Corporation reported an operating income of 364.00M and revenue of 2.93B, resulting in an operating margin of 12.4%.

ABT - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.

AES - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, The AES Corporation reported a net income of 46.00M and revenue of 2.93B, resulting in a net margin of 1.6%.

ABT - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.